Application of domestic single-port robotic surgical system in thyroid cancer.
10.13201/j.issn.2096-7993.2025.11.009
- Author:
Qian MA
1
;
Sicheng ZHANG
2
;
Longyue ZHANG
2
;
Jinyuan LIU
2
;
Ronghao SUN
2
;
Yuqiu ZHOU
2
;
Linjie MA
2
;
Chunyan SHUI
2
;
Yongcong CAI
2
;
Chao LI
1
Author Information
1. Department of Otolaryngology Head and Neck Surgery，the Affiliated Hospital of Southwest Medical University，Luzhou，646000，China.
2. Department of Head and Neck Surgery，Sichuan Clinical Research Center for Cancer，Sichuan Cancer Hospital & Institute，Sichuan Cancer Center，University of Electronic Science and Technology of China.
- Publication Type:Journal Article
- Keywords:
domestic robotic system;
single-port robotic system;
surgery;
thyroid cancer
- MeSH:
Humans;
Thyroid Neoplasms/surgery*;
Robotic Surgical Procedures/instrumentation*;
Male;
Female;
Adult;
Thyroidectomy/methods*;
Operative Time;
Middle Aged;
Prospective Studies
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(11):1044-1047
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the feasibility and preliminary efficacy of domestic single-port robotic surgical system in the surgical treatment of thyroid cancer. Methods:Thyroid cancer patients who underwent domestic single-port robotic surgery in the Department of Head and Neck Surgery of Sichuan Cancer Hospital from June 2024 to January 2025 were prospectively included. Clinical data, oncological characteristics, and perioperative indicators were systematically collected. Results:A total of 7 patients were included, including 3 males and 4 females, with an age of （34.57±10.26） years. All procedures were successfully completed without conversion to open surgery. Operative time was（180.00±30.41） minutes. Blood loss was（5.00[15.00 ]）mL. Postoperative drainage volume was （167.86±130.95） mL. The postoperative pathological results were all thyroid papillary carcinoma. There were no system failures, no device-related complications and adverse events were observed during the operation and perioperative period. No tumor recurrence or metastasis was observed during the follow-up period. Conclusion:Preliminary data indicate that the domestic single-port robotic surgical system is safe and feasible for the surgical treatment of thyroid cancer, providing a practical basis for subsequent multi-disease, multi-center, and large-sample studies.
